Literature DB >> 25424818

Investigation in a murine model of possible mechanisms of enhanced local reactions to post-primary diphtheria-tetanus toxoid boosters in recipients of acellular pertussis-diphtheria-tetanus vaccine.

Masaki Ochiai1, Yoshinobu Horiuchi, Chun-Ting Yuen, Catpagavalli Asokanathan, Akihiko Yamamoto, Kenji Okada, Michiyo Kataoka, Kevin Markey, Michael Corbel, Dorothy Xing.   

Abstract

In recipients primed with acellular pertussis diphtheria-tetanus combined vaccine (DTaP) an increased incidence of severe local reactions with extensive redness/swelling has been reported for each subsequent dose of diphtheria-tetanus based combination vaccine given as a booster. This has been attributed to residual active pertussis toxin (PT) in the primary vaccine. In this study, we investigated the possible contribution of the A-subunit enzymatic activity and the B-oligomer carbohydrate binding activity of residual PT in DTaP to local reactions in a murine model using Japanese DTaP batches produced before and after the introduction of a test for reversion of pertussis toxoid to toxin. Residual PT activity was correlated with the B-oligomer carbohydrate binding activity. The in vivo mouse footpad swelling model assay indicated that the B-oligomer carbohydrate binding activity and possibly other factors were associated with intensified sensitization to local reaction following diphtheria toxoid booster.

Entities:  

Keywords:  acellular pertussis vaccine; carbohydrate binding; enzymatic-HPLC assay; histamine sensitizing activity; local reaction

Mesh:

Substances:

Year:  2014        PMID: 25424818      PMCID: PMC4186053          DOI: 10.4161/hv.28952

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN: 2164-5515            Impact factor:   3.452


  36 in total

1.  Pertussis toxin has eukaryotic-like carbohydrate recognition domains.

Authors:  K Saukkonen; W N Burnette; V L Mar; H R Masure; E I Tuomanen
Journal:  Proc Natl Acad Sci U S A       Date:  1992-01-01       Impact factor: 11.205

2.  Developments in pertussis immunisation in Japan.

Authors:  M Kimura; H Kuno-Sakai
Journal:  Lancet       Date:  1990-07-07       Impact factor: 79.321

3.  Further characterization of Japanese acellular pertussis vaccine prepared in 1988 by 6 Japanese manufacturers.

Authors:  Y Sato; H Sato
Journal:  Tokai J Exp Clin Med       Date:  1988

4.  Overview of currently available Japanese acellular pertussis vaccines and future problems.

Authors:  H Kamiya; R Nii
Journal:  Tokai J Exp Clin Med       Date:  1988

5.  Pertussis vaccines in Japan.

Authors:  M Kimura; H Kuno-Sakai
Journal:  Acta Paediatr Jpn       Date:  1988-04

6.  Structure of a pertussis toxin-sugar complex as a model for receptor binding.

Authors:  P E Stein; A Boodhoo; G D Armstrong; L D Heerze; S A Cockle; M H Klein; R J Read
Journal:  Nat Struct Biol       Date:  1994-09

7.  Characterization of pertussis toxin analogs containing mutations in B-oligomer subunits.

Authors:  S Loosmore; G Zealey; S Cockle; H Boux; P Chong; R Yacoob; M Klein
Journal:  Infect Immun       Date:  1993-06       Impact factor: 3.441

8.  Local reactions after the fourth dose of acellular pertussis vaccine in South Australia.

Authors:  Michael S Gold; Sara Noonan; Maggi Osbourn; Stella Precepa; Ann E Kempe
Journal:  Med J Aust       Date:  2003-08-18       Impact factor: 7.738

9.  ADP-ribosylation of alpha i3C20 by the S1 subunit and deletion peptides of S1 of pertussis toxin.

Authors:  V Finck-Barbançon; J T Barbieri
Journal:  Biochemistry       Date:  1995-01-24       Impact factor: 3.162

10.  Site-specific alterations in the B oligomer that affect receptor-binding activities and mitogenicity of pertussis toxin.

Authors:  Y Lobet; C Feron; G Dequesne; E Simoen; P Hauser; C Locht
Journal:  J Exp Med       Date:  1993-01-01       Impact factor: 14.307

View more
  2 in total

Review 1.  Assays for Determining Pertussis Toxin Activity in Acellular Pertussis Vaccines.

Authors:  Kevin Markey; Catpagavalli Asokanathan; Ian Feavers
Journal:  Toxins (Basel)       Date:  2019-07-17       Impact factor: 4.546

2.  Subcutaneous administration of a fusion protein composed of pertussis toxin and filamentous hemagglutinin from Bordetella pertussis induces mucosal and systemic immune responses.

Authors:  Ali Torkashvand; Fariborz Bahrami; Minoo Adib; Soheila Ajdary
Journal:  Iran J Basic Med Sci       Date:  2018-07       Impact factor: 2.699

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.